Moran Wealth Management’s Palantir PLTR Stock Holding History

Moran Wealth Management’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14M	Buy	18,381 +14,514	+375%	+$1.98M	0.06%	313
2026 Q1	$566K	Buy	3,867 +1,409	+57%	+$215K	0.02%	394
2025 Q4	$437K	Buy	2,458 +15	+0.6%	+$2.71K	0.01%	411
2025 Q3	$446K	Buy	+2,443	New	+$396K	0.01%	416

Other funds holding PLTR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Moran Wealth Management's PLTR Position: Q2 2026 in Review

Moran Wealth Management increased its Palantir (PLTR) stake by 375% in Q2 2026, buying an estimated $1.98M and bringing the position to 18,381 shares worth $2.14M. The position accounts for 0.06% of the portfolio, ranked #313.

Moran Wealth Management first reported a position in PLTR in Q3 2025 and has held it in 4 quarters since. 2,838 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

Moran Wealth Management held 18,381 shares of Palantir worth $2.14M as of Q2 2026.
Moran Wealth Management bought 14,514 Palantir shares in Q2 2026, an estimated $1.98M.
Palantir made up 0.06% of Moran Wealth Management's portfolio in Q2 2026, its #313 holding.
Moran Wealth Management first reported a position in Palantir in Q3 2025 and has held it in 4 quarters since.
2,838 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.